Finian McGrath (Dublin North Central, Independent)
Link to this: Individually | In context

Question 311: To ask the Minister for Health and Children if she will support a matter (details supplied). [32442/08]

Mary Harney (Dublin Mid West, Progressive Democrats)
Link to this: Individually | In context

I understand the Deputy is referring to cancer services nationally and the Human Pamilloma Virus (HPV) vaccine. In September 2007, the Government endorsed the establishment by the Health Service Executive (HSE) of a National Cancer Control Programme to manage, organise and deliver cancer services. The implementation of the Programme involves significant realignment of services to move from the present fragmented system of care to one which is consistent with international best practice in cancer control. Significant progress has been made to date including the appointment of an interim Director to lead and manage the Programme. A national network, comprising of eight designated cancer centres has been decided and work is currently progressing on the transfer of symptomatic breast disease services from regional hospitals to the designated centres.

In relation to the HPV vaccine, I have considered all the relevant advice available to me in relation to the potential public health benefits of HPV vaccination in the prevention of cervical cancer and the wider policy implications for its possible introduction into the National Immunisation Programme. I accept the consensus view of the relevant expert bodies that the introduction of a universal high uptake vaccination programme in young girls, in conjunction with population based cervical screening, could significantly reduce overall cervical cancer rates.

I have asked the HSE to begin planning for the introduction of a vaccination programme for 12 year old girls to commence in September 2009, subject to cost and the level of uptake required for effectiveness being achievable. Accordingly, I have asked the HSE to examine and ascertain the likely uptake rates for such a programme, the cost of purchasing the vaccine based on the best competitive arrangements available in the market and the most efficient method of "roll-out" of the programme. In light of the current budgetary situation the introduction of a "catch up" programme for 13-15 year olds is not envisaged.